Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force… Read more
Market Cap & Net Worth: Establishment Labs Holdings Inc (ESTA)
Establishment Labs Holdings Inc (NASDAQ:ESTA) has a market capitalization of $1.84 Billion ($1.84 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7031 globally and #3818 in its home market, demonstrating a -9.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Establishment Labs Holdings Inc's stock price $63.48 by its total outstanding shares 29057868 (29.06 Million).
Establishment Labs Holdings Inc Market Cap History: 2018 to 2026
Establishment Labs Holdings Inc's market capitalization history from 2018 to 2026. Data shows growth from $796.77 Million to $1.84 Billion (13.08% CAGR).
Index Memberships
Establishment Labs Holdings Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.05% | #194 of 976 |
|
NASDAQ Composite
IXIC
|
$33.26 Trillion | 0.00% | #796 of 3165 |
Weight: Establishment Labs Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Establishment Labs Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Establishment Labs Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
8.06x
Establishment Labs Holdings Inc's market cap is 8.06 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $796.77 Million | $61.21 Million | -$21.10 Million | 13.02x | N/A |
| 2019 | $803.74 Million | $89.56 Million | -$38.15 Million | 8.97x | N/A |
| 2020 | $1.09 Billion | $84.68 Million | -$38.12 Million | 12.92x | N/A |
| 2021 | $1.96 Billion | $126.68 Million | -$41.14 Million | 15.50x | N/A |
| 2022 | $1.91 Billion | $161.70 Million | -$75.21 Million | 11.80x | N/A |
| 2023 | $752.31 Million | $165.15 Million | -$78.50 Million | 4.56x | N/A |
| 2024 | $1.34 Billion | $166.03 Million | -$84.60 Million | 8.06x | N/A |
Competitor Companies of ESTA by Market Capitalization
Companies near Establishment Labs Holdings Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Establishment Labs Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Establishment Labs Holdings Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Establishment Labs Holdings Inc's market cap moved from $796.77 Million to $ 1.84 Billion, with a yearly change of 13.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.84 Billion | -12.90% |
| 2025 | $2.12 Billion | +58.19% |
| 2024 | $1.34 Billion | +77.95% |
| 2023 | $752.31 Million | -60.56% |
| 2022 | $1.91 Billion | -2.87% |
| 2021 | $1.96 Billion | +79.57% |
| 2020 | $1.09 Billion | +36.08% |
| 2019 | $803.74 Million | +0.88% |
| 2018 | $796.77 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Establishment Labs Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.84 Billion USD |
| MoneyControl | $1.84 Billion USD |
| MarketWatch | $1.84 Billion USD |
| marketcap.company | $1.84 Billion USD |
| Reuters | $1.84 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.